Why Inovio's Stock Is Trading Higher Today
Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the global Phase 3 segment of its Phase 2/3 trial for INO-4800, its DNA vaccine candidate for COVID-19.
